Discover What’s New at the Institute
The experts at The Wertheim UF Scripps Institute for Biomedical Innovation & Technology, part of the University of Florida, collaborate with leading thinkers to tackle the toughest challenges in medicine, and search for new treatments.
POWERFUL Collaborations
Exceptional Scientists, Groundbreaking Discoveries
"We pursue a vital purpose, addressing humanity's unmet medical needs through research and education."
NEWS
historic gift
‘A Launchpad for Science’
The largest individual gift in UF history will name The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology and launch a public-private partnership that will drive the future of biomedical research and innovation.
Muscular Dystrophy and ALS
Research Spotlight: Chemist targets RNA to attack incurable disease from a new direction
A trailblazing scientist targets ALS, myotonic dystrophy, Parkinson’s, metastatic breast cancer, viral diseases and more by attacking key RNA, preventing disease-causing genes from being expressed.
The Wertheim UF Scripps Institute accounted for $101.2 million in research spending. “This new record sends an unmistakable signal that the University of Florida’s research enterprise is a rock-solid powerhouse, and the important work our researchers are doing is absolutely vital to the great state of Florida, the nation and the world,” said Mori Hosseini, UF Board of Trustees chair.
Dedicated to research excellence
External Advisory Board Convenes
Eight highly respected biomedical research and education leaders have joined the External Advisory Board of The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, bringing their significant expertise in academia, industry and government to institute leaders.
Drug discovery resources
Unique Resources for Finding New Medicines
Explore our unique resources and expertise, which are powering major discoveries that address a world of unmet medical needs.
outstanding results
Stand-Out Faculty Productivity Draws Accolades
One in five of our faculty holds a prestigious R35 Outstanding Investigator Award from the National Institutes of Health.
RESEARCH
Cancer innovation
Antibody-Cancer Drug Combo Vanquishes Lymphoma
A cancer-killing compound found in soil microbes, combined with a cancer-seeking antibody, shows promise against an aggressive type of lymphoma.
New research raises the possibility that a wider group of people in recovery from substance use disorders may benefit from a relapse-prevention compound designed by Courtney Miller, Ph.D., director of academic affairs and professor.
neuroscience
Scientists Discover How Fear Conditions the Brain
A specialized RNA with a memorable acronym, SLAMR, plays a role in fear conditioning, according to a discovery from scientists led by Sathya Puthanveettil, Ph.D.
CANCER AND IMMUNITY
Scientists find possible master switch for programming cancer immunotherapy
During tumor growth, a type of specialized white blood cells called CD8+ T cells rapidly multiply within the spleen and lymph nodes and acquire the ability to kill diseased cells. Finding the factors that cause T cells to function beyond the lymphoid system and in sites of infection or cancer has proven a tough challenge, but it’s essential for developing cancer-fighting immunotherapy strategies.
HIGH-THROUGHPUT SCREENING
High-throughput molecular screening
High-Throughput screening is a drug-discovery process widely used in both academia and the pharmaceutical industry. It leverages automation to quickly assay the biological or biochemical activity of a large number of drug-like compounds for the discovery of novel small molecule ligands against receptors, enzymes, ion-channels and other pharmacological targets.
BREAST CANCER
Taking aim at breast cancer from a different angle
“Cancer patients whose tumor growth is boosted by hormones such as estrogen and progesterone need more options. We’re taking a different approach, looking at the structure of the hormones’ interacting molecules as potential targets to silence cancer’s growth signal.” — Patrick Griffin, PhD, Scientific Director and Professor, UF Scripps Department of Molecular Medicine
LATEST News
Innovations and Discoveries
Click here to keep up with the latest science from UF Scripps.